SaveHealth Canada/FDA ApprovedUnited StatesCanadaNew Pill for a Gene-Related Advanced Lung CancerHyrnuo (sevabertinib) for HER2 TKD-mutant NSCLCHyrnuo (sevabertinib) is a pill for adults with advanced lung cancer and a certain HER2 gene mutation.September 4, 2026